Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis
Author(s) -
Giulia Galli,
Stefano Cavalieri,
Lorenza Di Guardo,
Carolina Cimminiello,
Federico Nichetti,
Francesca Corti,
Monica Alicia Garcia,
Brigida Pappalardi,
C. Fallai,
Filippo de Braud,
Marco Platania,
Michele Del Vecchio
Publication year - 2019
Publication title -
oncology research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000497211
Subject(s) - immunotherapy , radiation therapy , medicine , melanoma , oncology , retrospective cohort study , metastatic melanoma , brain metastasis , cancer research , cancer , metastasis
Up to 40% of patients with metastatic melanoma (MM) develop brain metastases. Radiotherapy (RT) may potentiate the effects of immunotherapy (IO), even on distant sites (abscopal effect).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom